article thumbnail

AI tool could help doctors ID breast cancers vulnerable to Enhertu

Bio Pharma Dive

Tumors with low- and ultra-low levels of a protein called HER2 are treatable with Enhertu, but harder to identify. New research shows AI can improve diagnosis.

Doctors 157
article thumbnail

Doctors Discover Needle Lodged in 80-Year-Old Woman’s Brain

AuroBlog - Aurous Healthcare Clinical Trials blog

An elderly woman in Russia’s Far East was revealed on Wednesday to have lived for 80 years with an inch-long needle in her brain, after doctors made the unexpected discovery during a CT scan. Doctors believe the woman was the victim of a failed infanticide carried out by her parents, and said they would not […]

Doctors 246
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Should doctors refuse to treat obese patients?

World of DTC Marketing

IN BRIEF: Doctors are not required to treat obese patients who won’t do anything to lose weight but the problem is more than reminding patients they need to get exercise and drop pounds. Susan knew she needed to lose weight, especially when her doctor told her that her A1C indicated that she was prediabetic.

Doctors 250
article thumbnail

Doctors are consumers too! How DTC media impacts HCPs

Bio Pharma Dive

The findings have implications for how pharma teams should think about their DTC and HCP efforts — they are no longer two separate marketing channels.

Doctors 307
article thumbnail

An app can never replace a doctor

World of DTC Marketing

million doctors, nurses, and midwives expected by 2030. Vastaamo has filed for bankruptcy but left many Finns wary of telling doctors personal details, says Joni Siikavirta, a lawyer representing the company’s patients “ No universal standards for storing “emotional data” exist. The post An app can never replace a doctor.

Doctors 208
article thumbnail

Alzheimer’s doctors see promise, limits in Lilly’s latest drug data

Bio Pharma Dive

While some see the new donanemab results as adding to a “watershed moment” in Alzheimer’s research, others say they reinforce the limitations of so-called anti-amyloid therapies.

Doctors 299
article thumbnail

November 21, 2024: Are Pragmatic Trials Living Up to the Promise of Improving Representativeness?

Rethinking Clinical Trials

The post November 21, 2024: Are Pragmatic Trials Living Up to the Promise of Improving Representativeness?

Trials 316